Background: Isomerization of aspartate to isoaspartate (isoAsp) on aging causes protein damage and malfunction. Protein-L-isoaspartyl methyltransferase (PIMT) performs a neuroprotective role by repairing such residues. A hexapeptide, Val-Tyr-Pro-(isoAsp)-His-Ala (VA6), a substrate of PIMT, is shown to form fibrils, while the normal Asp-containing peptide does not. Considering the role of PIMT against epileptic seizure, the combined effect of PIMT and two antiepileptic drugs (AEDs) (valproic acid and stiripentol) was investigated for anti-fibrillation activity.
Methods: Structural/functional modulations due to the binding of AEDs to PIMT were investigated using biophysical techniques. Thioflavin T (ThT) fluorescence assay and microscopic methods were employed to study fibril formation by VA6. In vitro experiments with PC12 cells were carried out with PIMT/AEDs.
Results: ThT assay indicated reduction of fibrillation of VA6 by PIMT. AEDs stabilize PIMT, bind close to the cofactor binding site, possibly exerting allosteric effect, increase the enzymatic activity, and anti-fibrillation efficacy. Furthermore, Aβ42, implicated in Alzheimer's disease, undergoes β-sheet to α-helix transition in presence of PIMT. Studies with PC12 derived neurons showed that PIMT and PIMT/AEDs exerted neuroprotective effect against anti-NGF induced neurotoxicity. This was further validated against neurotoxicity induced by Aβ42 in primary rat cortical neurons.
Conclusions: The study provides a new perspective to the role isoAsp in protein fibrillation, PIMT in its prevention and AEDs in enhancing the activity of the enzyme.
General Significance: IsoAsp, with an additional C atom in the main-chain of polypeptide chain, may make it more susceptible to fibrillation. PIMT alone, or in association with AEDs prevents this.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbagen.2019.129500 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isoaspartate formation and irreversible aggregation of collapsin response mediator protein 2: implications for the etiology of epilepsy and age-related cognitive decline.
Amino Acids
December 2024
Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, 92697-3900, USA.
Collapsin response mediator protein 2 (CRMP2) functions in the genesis and activity of neuronal connections in mammalian brain. We previously reported that a protein coincident with CRMP2 on 2D-gels undergoes marked accumulation of abnormal L-isoaspartyl sites in brain extracts of mice missing the repair enzyme, protein L-isoaspartyl methyltransferase (PIMT). To confirm and explore the significance of isoaspartyl damage in CRMP2, we expressed and purified recombinant mouse CRMP2 (rCRMP2).
View Article and Find Full Text PDFCollapsin response mediator protein 2 (CRMP2) functions in the genesis and activity of neuronal connections in mammalian brain. We previously reported that a protein coincident with CRMP2 on 2D-gels undergoes marked accumulation of abnormal L-isoaspartyl sites in brain extracts of mice missing the repair enzyme, protein L-isoaspartyl methyltransferase (PIMT). To conflrm and explore the signiflcance of isoaspartyl damage in CRMP2, we expressed and purifled recombinant mouse CRMP2 (rCRMP2).
View Article and Find Full Text PDFisoAsp-Quest: Workflow development for isoAsp identification using database searches.
J Biochem
October 2024
Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8565, Japan.
A recent study reported that isomerization of aspartyl residues (Asp) occurs in various tissues and proteins in vivo. For a comprehensive analysis of post-translational modifications, the MS-based proteomic approach is a straightforward method; however, the isomerization of Asp does not alter its molecular weight. Therefore, a unique method is required to analyze Asp isomers using mass spectrometry.
View Article and Find Full Text PDFPCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis.
Am J Cancer Res
August 2024
Institute of Clinical Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China Hengyang 421200, Hunan, China.
Protein L-isoaspartyl (D-aspartyl) methyltransferase (PIMT, gene name PCMT1) is an enzyme that repairs proteins with altered aspartate residues by methylation, restoring their normal structure and function. This study conducted a comprehensive analysis of PCMT1 in pan-cancer. The Cancer Genome Atlas, Human Protein Atlas website, and the Genotype-Tissue Expression were utilized in analysis of PCMT1 expression.
View Article and Find Full Text PDFAutoinhibited Protein Database: a curated database of autoinhibitory domains and their autoinhibition mechanisms.
Database (Oxford)
August 2024
Department of Biomedical Engineering, Chung-Ang University, Seoul 06974, South Korea.
Article Synopsis
- Autoinhibition is a key self-regulation mechanism in cell signaling that ensures signals only pass through in the presence of specific inputs, making autoinhibited proteins relevant in human diseases as potential targets for therapy.
- The newly established Autoinhibited Protein Database (AiPD) compiles standardized information on autoinhibited proteins, including details on autoinhibitory domains, their targets, and their roles in diseases.
- AiPD features a significant collection of both experimentally characterized and computationally predicted autoinhibited proteins, making it a crucial resource for researchers focusing on autoinhibition mechanisms and drug discovery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!